Market Overview:
The global Indacaterol market is expected to grow at a CAGR of XX% and reach a value of USD XX million by 2030. The market is segmented by type, application and region. By type, the market is segmented into 150mcg capsules, 300mcg capsules and other. By application, the market is segmented into hospital, clinic, drug center and other. By region, the market is divided into North America, Latin America Europe Asia Pacific Middle East & Africa.
Product Definition:
Indacaterol is a long-acting beta2-agonist bronchodilator used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It relaxes the airways, making it easier to breathe. Indacaterol is important because it helps improve lung function and reduces exacerbations in people with COPD.
150mcg Capsules:
150MCG capsules are used for the treatment of bronchospasm in patients with reversible pulmonary hypertension. It is also used as a maintenance therapy in these patients. Indacaterol works by decreasing the production of prostaglandins which causes cough suppression and reduces airway inflammation.
300mcg Capsules:
300MCG capsules are used in Indacaterol, a drug which is inhaled for the treatment of bronchospasm. It works by increasing airway opening capacity and reducing inflammation of the lungs. The 300 MCG capsule contains around 1/10th dose of indacaterol and has to be ingested with food to avoid ill effect such as stomach irritation.
The capsules are available in different colors including white, yellow, blue.
Application Insights:
Indacaterol is used for the treatment of bronchospasm in patients suffering from asthma. The product is also used for the prevention of exercise-induced bronchospasm (EIB) in patients suffering from asthma and other allergic diseases. Based on application, the global indacaterol market has been segmented into hospital, clinic, drug center and others. Hospital was estimated as largest revenue-generating segment owing to increasing prevalence of respiratory disorders coupled with rising awareness about available treatment options among consumers/patients at large. Increasing number of hospitals offering outpatient clinics that provide access to a wide range of medicines through direct patient consultation rooms will further boost industry growth over forecast period.
The use of indacaterol inhalation powder by healthcare professionals for emergency treatment during an asthmatic attack or when oral medication cannot be taken due to a medical condition such as diabetes mellitus or pregnancy will drive demand globally over next eight years.
Regional Analysis:
North America dominated the global indacaterol market in 2017. In addition, growing awareness regarding drug usage is also anticipated to drive the regional market growth. Moreover, presence of key manufacturers such as Pfizer Inc.; Ortho-McNeil Pharmaceutical; and Merck & Co., Inc.; will fuel product demand in near future.
Asia Pacific is expected to be one of the fastest-growing regions during the forecast period due to rising geriatric population proneto various chronic disorders coupled with high unmet medical needs in emerging economies such as China.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental factors. This is expected to drive the demand for indacaterol, as it is a long-acting beta2-agonist (LABA) drug that helps in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD).
- Growing awareness about asthma and COPD: There is a growing awareness among people about asthma and COPD, which are major causes of mortality across the world. This is expected to increase the demand for indacaterol as it helps in better management of these conditions.
- Rising geriatric population: The geriatric population (aged 65 years or above) is growing at a rapid pace across the world, which will lead to an increase in cases of respiratory diseases such as asthma and COPD. Indacaterol offers an effective treatment option for these conditions, thereby driving its market growth.
- Technological advancements in inhalers: Inhalers are becoming more technologically advanced with each passing day, offering better patient compliance rates owing to their ease-of-use features such as dose counters etcetera Indacaterol belongs to this category of inhalers, making it more popular among patients worldwide.. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Indacaterol Market Research Report
By Type
150mcg Capsules, 300mcg Capsules, Other
By Application
Hospital, Clinic, Drug Center, Other
By Companies
Sunovion Pharmaceuticals, Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Indacaterol Market Report Segments:
The global Indacaterol market is segmented on the basis of:
Types
150mcg Capsules, 300mcg Capsules, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Drug Center, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sunovion Pharmaceuticals
- Novartis
Highlights of The Indacaterol Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 150mcg Capsules
- 300mcg Capsules
- Other
- By Application:
- Hospital
- Clinic
- Drug Center
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Indacaterol Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Indacaterol is a medication used to treat asthma. It works by relaxing the airways and reducing inflammation.
Some of the major companies in the indacaterol market are Sunovion Pharmaceuticals, Novartis.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Indacaterol Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Indacaterol Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Indacaterol Market - Supply Chain
4.5. Global Indacaterol Market Forecast
4.5.1. Indacaterol Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Indacaterol Market Size (000 Units) and Y-o-Y Growth
4.5.3. Indacaterol Market Absolute $ Opportunity
5. Global Indacaterol Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Indacaterol Market Size and Volume Forecast by Type
5.3.1. 150mcg Capsules
5.3.2. 300mcg Capsules
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Indacaterol Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Indacaterol Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Drug Center
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Indacaterol Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Indacaterol Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Indacaterol Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Indacaterol Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Indacaterol Demand Share Forecast, 2019-2026
9. North America Indacaterol Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Indacaterol Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Indacaterol Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Drug Center
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Indacaterol Market Size and Volume Forecast by Type
9.7.1. 150mcg Capsules
9.7.2. 300mcg Capsules
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Indacaterol Demand Share Forecast, 2019-2026
10. Latin America Indacaterol Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Indacaterol Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Indacaterol Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Drug Center
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Indacaterol Market Size and Volume Forecast by Type
10.7.1. 150mcg Capsules
10.7.2. 300mcg Capsules
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Indacaterol Demand Share Forecast, 2019-2026
11. Europe Indacaterol Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Indacaterol Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Indacaterol Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Drug Center
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Indacaterol Market Size and Volume Forecast by Type
11.7.1. 150mcg Capsules
11.7.2. 300mcg Capsules
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Indacaterol Demand Share, 2019-2026
12. Asia Pacific Indacaterol Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Indacaterol Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Indacaterol Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Drug Center
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Indacaterol Market Size and Volume Forecast by Type
12.7.1. 150mcg Capsules
12.7.2. 300mcg Capsules
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Indacaterol Demand Share, 2019-2026
13. Middle East & Africa Indacaterol Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Indacaterol Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Indacaterol Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Drug Center
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Indacaterol Market Size and Volume Forecast by Type
13.7.1. 150mcg Capsules
13.7.2. 300mcg Capsules
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Indacaterol Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Indacaterol Market: Market Share Analysis
14.2. Indacaterol Distributors and Customers
14.3. Indacaterol Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sunovion Pharmaceuticals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Novartis
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. COMPANY3
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
